⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9362 | 1.00 | — | — | |
| Water SCHEMBL5487305 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL277848 | 0.96 | — | — | |
| SCHEMBL4149569 | 0.96 | — | — | |
| SCHEMBL1965919 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL3433151 | 0.93 | TSHR (0.38) | — | |
| Hydrochloric Acid SCHEMBL7039746 | 0.93 | — | — | |
| Hydroxyamine SCHEMBL17187300 | 0.93 | — | — | |
| SCHEMBL10629515 | 0.90 | — | — | |
| SCHEMBL15466682 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8933082-B2 | Materials and methods for suppressing and/or treating neurofibroma and related tumors | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) | 2015-01-13 | — | — | US | claimed |
| US-8765777-B2 | Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection | EMORY UNIVERSITY (US) | 2014-07-01 | — | — | US | claimed |
| US-20140121214-A1 | MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING NEUROFIBROMA AND RELATED TUMORS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) | 2014-05-01 | — | — | US | claimed |
| US-20120071491-A1 | Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates | NEKTAR THERAPEUTICS (US) | 2012-03-22 | — | — | US | claimed |
| US-20110281867-A1 | COMPOSITIONS AND METHODS OF USE FOR TYROSINE KINASE INHIBITORS TO TREAT PATHOGENIC INFECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-11-17 | — | — | US | claimed |
| US-20110201619-A1 | Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders | HEINRICH MICHAEL | 2011-08-18 | — | — | US | claimed |
| US-20110195975-A1 | MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING NEUROFIBROMA AND RELATED TUMORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-08-11 | — | — | US | claimed |
| EP-1725295-B1 | COMPOSITIONS AND USE OF TYROSINE KINASE INHIBITORS TO TREAT PATHOGENIC INFECTION | UNIV EMORY (US) | 2010-09-15 | — | — | EP | claimed |
| US-20100210596-A1 | USE OF AMINOPYRIMIDINE COMPOUNDS IN THE TREATMENT OF IMMUNE DISORDERS | NIH-DIETR | 2010-08-19 | — | — | US | claimed |
| US-20090221519-A1 | COMBINATIONS OF RECEPTOR TYROSINE KINASE INHIBITOR WITH AN A1-ACIDIC GLYCOPROTEIN BINDING COMPOUND | NOVARTIS AG (CH) | 2009-09-03 | — | — | US | claimed |
| WO-2002022597-A1 | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES | NOVARTIS AG (CH) | 2002-03-21 | — | — | WO | claimed |
| WO-2001064200-A2 | USE OF PDGF RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF DIABETIC NEPHROPATHY | NOVARTIS AG (CH) | 2001-09-07 | — | — | WO | claimed |
| WO-2001047507-A2 | COMBINATIONS OF RECEPTOR TYROSINE KINASE INHIBITOR WITH AN A1-ACIDIC GLYCOPROTEIN BINDING COMPOUND | NOVARTIS AG (CH) | 2001-07-05 | — | — | WO | claimed |
| EP-0564409-B1 | Pyrimidin derivatives and process for their preparation | NOVARTIS AG (CH) | 2000-01-19 | — | — | EP | claimed |
| US-5612340-A | ANTITUMOR AGENTS | CIBA-GEIGY CORPORATION (US) | 1997-03-18 | — | — | US | claimed |
| US-5521184-A | ANTITUMOR AGENTS; imatinib mesylate | CIBA-GEIGY CORPORATION (US) | 1996-05-28 | — | — | US | claimed |
| EP-0672035-A1 | PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1995-09-20 | — | — | EP | claimed |
| WO-1995009847-A1 | PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1995-04-13 | — | — | WO | claimed |
| US-5244879-A | 23-nor-23-oxa avermectin analogs are active anthelmintic agents | MERCK & CO., INC. (US) | 1993-09-14 | — | — | US | claimed |
| US-5162363-A | 23-nor-23-thia avermectin analogs are active anthelmintic agents | MERCK & CO., INC. (US) | 1992-11-10 | — | — | US | claimed |